AKER HAZEL M 4/A
4/A · Oncternal Therapeutics, Inc. · Filed Jul 31, 2020
Insider Transaction Report
Form 4/AAmended
AKER HAZEL M
General Counsel
Transactions
- Award
Stock Option
2020-03-17+11,080→ 11,080 totalExercise: $3.33Exp: 2030-03-17→ Common Stock (11,080 underlying)
Footnotes (2)
- [F1]The original Form 4 reported the acquisition of the Stock Options in the "D" column of Column 5. This amendment is being filed to correctly report the acquisition of the Stock Options in the "A" column of Column 5.
- [F2]Fully vested on grant date.